| No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
| 1 |
chr2:180299800-180308400 |
Weak transcription |
H9 Cell Line |
embryonic stem cell
|
| 2 |
chr2:180306400-180308800 |
Weak transcription |
Skeletal Muscle Male |
skeletal muscle
|
| 3 |
chr2:180306600-180308600 |
Weak transcription |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
| 4 |
chr2:180306600-180311400 |
Strong transcription |
Liver |
Liver
|
| 5 |
chr2:180306800-180309000 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
| 6 |
chr2:180307000-180309800 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
| 7 |
chr2:180307000-180310200 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
| 8 |
chr2:180307200-180310400 |
Enhancers |
ES-WA7 Cell Line |
embryonic stem cell
|
| 9 |
chr2:180307400-180308200 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
| 10 |
chr2:180307400-180308200 |
Enhancers |
Fetal Heart |
heart
|
| 11 |
chr2:180307400-180308600 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
| 12 |
chr2:180307400-180309800 |
Enhancers |
HUES64 Cell Line |
embryonic stem cell
|
| 13 |
chr2:180307400-180310200 |
Enhancers |
H1 Cell Line |
embryonic stem cell
|
| 14 |
chr2:180307400-180310200 |
Enhancers |
iPS-18 Cell Line |
embryonic stem cell
|
| 15 |
chr2:180307400-180310600 |
Enhancers |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
| 16 |
chr2:180307400-180312800 |
Enhancers |
NHEK |
skin
|
| 17 |
chr2:180307600-180308200 |
Enhancers |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
| 18 |
chr2:180307600-180308200 |
Enhancers |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
| 19 |
chr2:180307600-180308200 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
| 20 |
chr2:180307600-180308600 |
Flanking Active TSS |
HUES6 Cell Line |
embryonic stem cell
|
| 21 |
chr2:180307600-180309800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
| 22 |
chr2:180307800-180308200 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
| 23 |
chr2:180307800-180308200 |
Flanking Active TSS |
HUES48 Cell Line |
embryonic stem cell
|
| 24 |
chr2:180307800-180308200 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
| 25 |
chr2:180307800-180308200 |
Flanking Active TSS |
Primary neutrophils fromperipheralblood |
blood
|
| 26 |
chr2:180307800-180308200 |
Enhancers |
Placenta |
Placenta
|
| 27 |
chr2:180307800-180308200 |
Enhancers |
Right Atrium |
heart
|
| 28 |
chr2:180307800-180308600 |
Flanking Active TSS |
iPS-15b Cell Line |
embryonic stem cell
|
| 29 |
chr2:180307800-180309200 |
Genic enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
| 30 |
chr2:180307800-180310200 |
Enhancers |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
| 31 |
chr2:180307800-180310600 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
| 32 |
chr2:180307800-180320800 |
Weak transcription |
HepG2 |
liver
|
| 33 |
chr2:180308000-180308200 |
Enhancers |
ES-I3 Cell Line |
embryonic stem cell
|
| 34 |
chr2:180308000-180308200 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
| 35 |
chr2:180308000-180308200 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
| 36 |
chr2:180308000-180308200 |
Enhancers |
Fetal Muscle Leg |
muscle
|
| 37 |
chr2:180308000-180308200 |
Weak transcription |
Gastric |
stomach
|
| 38 |
chr2:180308000-180308200 |
Enhancers |
Lung |
lung
|
| 39 |
chr2:180308000-180308600 |
Enhancers |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
| 40 |
chr2:180308000-180308600 |
Enhancers |
HMEC |
breast
|
| 41 |
chr2:180308000-180309200 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
| 42 |
chr2:180308000-180309800 |
Enhancers |
Fetal Intestine Large |
intestine
|
| 43 |
chr2:180308000-180310400 |
Enhancers |
iPS-20b Cell Line |
embryonic stem cell
|
